Hope Rising…MSD’s Ebola Vaccine Gets WHO Prequalification Status


Merck known as MSD Thursday said its ERVEBO (Ebola Zaire Vaccine – rVSVΔ-ZEBOV-GP live) has been awarded prequalification status by the World Health Organization (WHO).

ERVEBO is the first vaccine to be prequalified by the WHO for the prevention of Ebola Virus Disease.

WHO prequalification followed the European Commission’s grant of a conditional marketing authorisation to ERVEBO on November 11.

ERVEBO is currently under Priority Review with the US Food and Drug Administration (FDA) with a target action date of March 14, 2020.

WHO prequalification means that ERVEBO has met the WHO’s standards of quality, efficacy and tolerability, which, in conjunction with other criteria, offers guidance to the United Nations (UN) and other global health entities in making relevant vaccine decisions.

Importantly, prequalification status allowed a vaccine to be procured and purchased by the UN, now allowing ERVEBO to be considered as a vaccine to be included in a global…

View original post 105 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: